Legal standing requirements for environmental health lawsuits

That ruling, issued on September 24, 2024, is no longer in force: on May 21, 2026, the Ninth Circuit vacated it and sent the case back.

That reversal matters. The 2024 decision did not become a final, nationwide order requiring the EPA to regulate fluoride, and federal law does not require every municipality to fluoridate its water. The case instead exposes the legal hurdles that shape environmental health litigation: plaintiffs must show they have a right to be in court, use the statutory route Congress provided, and build a record that can survive judicial review. A strong claim about public health does not, by itself, clear those hurdles.

Article III standing: who gets through the courthouse door

Federal courts do not decide abstract disputes about whether a chemical may pose a risk. Under Article III of the Constitution, a plaintiff must show a concrete injury, connect that injury to the defendant’s conduct, and demonstrate that a favorable court decision is likely to address it. The Supreme Court set out the familiar framework in Lujan v. Defenders of Wildlife in 1992.

Each part does a different job. Injury in fact asks what happened, or what is sufficiently likely to happen, to this plaintiff. Traceability asks whether the injury can fairly be linked to the agency action being challenged. Redressability asks whether the requested ruling could change the plaintiff’s situation.

Those requirements can turn a broad toxic-exposure dispute into a demanding case about individual facts. A community may be worried about a drinking-water additive. A plaintiff still needs to show their own exposure and a specific risk, rather than rely only on a generalized concern shared by the public. The court is not being asked to issue an advisory opinion on public health policy. It is being asked to resolve a dispute involving people with a concrete stake.

The table is a map, not a pleading formula. The evidence needed depends on the claim and the record. In water-toxicity litigation, exposure may turn on where a person lives, which water system serves them, and whether the challenged chemical is present at a relevant level. The injury theory must also match the remedy being sought. If a plaintiff asks a court to review an EPA decision, they need to explain how that decision bears on their own exposure and why the requested judicial action could make a practical difference.

A public-health concern becomes a federal case only when the plaintiffs can connect it to their own injury, the agency action, and a remedy the court can actually grant.

That is one reason the phrase “standing to sue the EPA over water standards” can mislead. There is no single standing shortcut for environmental plaintiffs. A statutory right to petition or seek review does not erase Article III. Congress can create procedural rights, but plaintiffs still must satisfy the Constitution’s case-or-controversy requirement.

TSCA Section 21: a petition route, not a standing waiver

The Toxic Substances Control Act, enacted in 1976, gives citizens a route to ask the EPA to begin rulemaking on chemical risks. Section 21, codified at 15 U.S.C. § 2620, provides for a citizen petition and a form of de novo judicial review in federal district court when the agency denies the petition.

The route matters because a plaintiff must identify the legal authority for the request and follow its procedures. Section 21 is not simply a general invitation to ask a judge to supervise chemical policy. It ties the court case to a petition asking the EPA to initiate rulemaking under TSCA. The petition, the agency’s response, and the relief requested help define what the court can review.

“De novo” review can sound like a clean restart. It does not mean every other constraint disappears. The statutory standard shapes the review, and Article III still governs access to federal court. Plaintiffs must establish their own concrete injury, traceability, and redressability alongside the requirements of Section 21.

The legal framework also changed in 2016. The Frank R. Lautenberg Chemical Safety for the 21st Century Act amended TSCA Section 6(b)(4)(A), directing the EPA not to consider costs or other non-risk factors when evaluating whether a chemical presents an unreasonable risk of injury to health or the environment. That amendment bears on the agency’s risk evaluation. It does not settle whether a particular plaintiff has standing, nor does it turn a risk finding into an automatic regulatory order.

For readers following a TSCA case, the procedural route is worth tracking in sequence:

1. The petition identifies the requested agency action. The claim begins with a request that the EPA initiate rulemaking under the statute, not with a free-standing demand that the court set national policy.

2. The EPA responds. The agency’s decision, including a denial, supplies the next procedural event. The grounds for that decision matter to the dispute.

3. The plaintiff seeks judicial review under Section 21. The case must fit the statutory pathway and satisfy the relevant review standard.

4. The plaintiff establishes Article III standing. Individual injury, traceability, and redressability remain constitutional requirements throughout.

5. The court addresses the merits on a proper record. Even a plaintiff who clears standing must still prove the legal claim and obtain a remedy supported by the statute.

This is where legal requirements for public health litigation become less tidy than the public debate. The petition process concerns agency action and chemical risk. Standing concerns the plaintiffs’ personal stake. Merits review concerns whether the governing law supports the requested outcome. These questions overlap in the facts, but they are not interchangeable.

Injury and causation: the evidentiary pressure point

In water toxicity cases, proving harm is often the point where public concern meets evidentiary scrutiny. A plaintiff may allege exposure to a chemical and a health risk. The court will need a record that makes the claim individual and concrete enough for standing, while the merits may require evidence relevant to the statutory risk question.

That distinction is easy to blur. Evidence that a substance can pose a risk may be relevant to the merits. It does not automatically show that a particular plaintiff has been exposed, faces a specific risk, or can obtain relief through the lawsuit. Conversely, evidence of a person’s exposure does not, by itself, establish that the EPA violated TSCA.

Causation evidence in fluoride litigation therefore has more than one legal job. It may help establish the link between a plaintiff’s circumstances and the challenged agency action. It may also inform the underlying dispute about risk. The court has to assess each use in its proper place, rather than treating a general scientific conclusion as a substitute for every element of the case.

A useful way to read the record is to ask what each piece of evidence is supposed to prove:

• Exposure evidence connects the plaintiff to the relevant water system and alleged chemical exposure.
• Risk evidence bears on whether the chemical presents the kind of health or environmental risk addressed by TSCA.
• Causation evidence links the alleged injury or risk to the agency action under challenge.
• Remedy evidence explains how the requested court order could change the plaintiff’s position.

This does not mean each lawsuit requires the same proof or that the list exhausts what a court may consider. It means a claim can falter when evidence is asked to do work it cannot do. Broad evidence about a population-level concern may not establish an individual plaintiff’s standing. A personal account of exposure may not answer the statutory question about unreasonable risk. And a favorable merits conclusion cannot cure a missing constitutional link.

The phrase “environmental health class action criteria” also needs care. A class action adds a separate set of procedural questions about whether the proposed group can be treated collectively. Class certification does not replace Article III standing, and a large group does not make an individual injury concrete by arithmetic. The named plaintiffs must establish their own standing. The class must then satisfy the applicable requirements for collective treatment. Those are related screens, not one combined test.

Food & Water Watch v. EPA: the ruling that did not survive

The case began with a citizen petition filed with the EPA in 2016, seeking to prohibit water fluoridation. In Food & Water Watch, Inc. v. EPA, No. 3:17-cv-02162-EMC, the Northern District of California issued its decision on September 24, 2024. It held that fluoridation at 0.7 mg/L presented an unreasonable risk of injury to public health under TSCA.

That finding attracted attention because it addressed the statutory risk question at the heart of the dispute. But the procedural history did not stop there. On May 21, 2026, the Ninth Circuit, in No. 25-384, vacated and remanded the district court’s ruling. The appellate court concluded that the trial court violated the party-presentation principle by declining to decide the case on the initial trial record and holding it in abeyance for an unsubmitted study.

The party-presentation principle is a basic constraint on adjudication: courts generally decide the case the parties have presented, using the record properly before them. The Ninth Circuit’s action means the district court’s 2024 ruling has been vacated. It cannot be described as a final, binding ruling that the EPA must regulate fluoride. The case returns to the district court; the eventual outcome after remand remains unresolved in the facts available here.

The distinction between vacatur and a merits endorsement is not a technical footnote. A vacated ruling no longer carries the force of the district court judgment it replaced. The appellate court’s procedural holding also should not be inflated into a final determination of the underlying fluoride-risk question. It addressed how the trial court handled the case and record. The next legal steps may affect the dispute, but they do not retroactively restore the vacated decision.

For readers following the docket, keep four questions separate:

• What did the district court decide in 2024?
• What did the Ninth Circuit vacate in 2026, and why?
• What remains for the district court to consider on remand?
• What action, if any, will the EPA take after the litigation proceeds?

The last question is open. The available record does not establish what regulatory action the EPA will take following remand. Nor does the case make local water-treatment decisions disappear. Municipalities retain jurisdiction over their public water treatment choices; federal litigation over EPA action is a different legal track.

Reading the next phase of environmental health litigation

The litigation offers a practical route for reading other challenges to drinking-water standards. Start with the statute. Identify whether the plaintiff is challenging a rule, an agency denial, or a failure to take a requested action. Then identify the standing theory. Who faces the claimed injury, what connects that person to the agency conduct, and how would the requested remedy help?

Next, read the procedural posture before relying on a headline. A district court ruling may be appealed, stayed, vacated, or remanded. Those words describe different legal consequences. In this case, the 2024 finding cannot be presented as the current final outcome after the Ninth Circuit vacated it in May 2026.

Finally, distinguish an agency risk determination from a local treatment mandate. TSCA supplies a federal framework for chemical-risk action. It does not, on the facts here, establish a nationwide requirement that every water system fluoridate or stop fluoridating. The federal case concerns the EPA’s statutory responsibilities and the court’s review of agency action. Local decisions remain part of the landscape.

The route is demanding by design. Article III keeps federal courts focused on concrete disputes. TSCA Section 21 supplies a citizen-petition mechanism, with its own procedures and review. The merits depend on the statute and the record, and appellate courts can send a case back when the trial process crosses a procedural line.

That is the map. It offers no guarantee that a court will reach the scientific dispute on the timetable advocates want, or that a ruling will produce the regulatory result they seek. In environmental health litigation, the public claim may be urgent. The docket still moves one legal gate at a time.